Sodium-glucose exchanger 2 inhibitor canagliflozin promotes mitochondrial metabolism and alleviates salt-induced cardiac hypertrophy via preserving SIRT3 expression.
Zhao Y, Lu Z, Zhang H, Wang L, Sun F, Li Q, Cao T, Wang B, Ma H, You M, Zhou Q, Wei X, Li L, Liao Y, Yan Z, Liu D, Gao P, Zhu Z.
Zhao Y, et al. Among authors: cao t.
J Adv Res. 2024 May 12:S2090-1232(24)00173-5. doi: 10.1016/j.jare.2024.04.030. Online ahead of print.
J Adv Res. 2024.
PMID: 38744404
Free article.